Insulin analogues: impact of cell model characteristics on results and conclusions regarding mitogenic properties.
Kellerer
M
M
Medizinische Klinik und Poliklinik, Abteilung Innere IV, Eberhard-Karls-Universität, Tübingen, Germany.
Häring
H U
HU
D000818:Animals; D002460:Cell Line; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000069036:Insulin Glargine; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D008934:Mitogens / Q000494:pharmacology*; D017526:Receptor, IGF Type 1 / Q000187:drug effects / Q000378:metabolism; D011972:Receptor, Insulin / Q000187:drug effects / Q000378:metabolism; D014407:Tumor Cells, Cultured
D007328:Insulin; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D008934:Mitogens; D000069036:Insulin Glargine; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin